Theradaptive has announced that the US Food and Drug Administration (FDA) has granted breakthrough medical device designation for the use of its OsteoAdapt SP spinal implant in anterior lumbar interbody fusion.
This marks the third breakthrough designation for Theradaptive in spinal fusion, along with transforaminal interbody and posterolateral fusion, allowing it to address over 90% of lumbar spinal fusion procedures.
Under the breakthrough devices program, the FDA will provide Theradaptive with priority review and interactive communication regarding device development and clinical trial protocols during the premarket review process. Expedited review of the premarket approval is included as a benefit.
Jay Jolley, the founder of Southeastern Spine, Brain and Joint and the Riverfront Surgery Center (Chattanooga, USA), said: “Evidenced by this being the third breakthrough designation awarded by the FDA to Theradaptive for this technology, there is a significant need for it in the bone grafting space.
“I see immense opportunity and advantages to the utility of OsteoAdapt SP in anterior lumbar interbody fusion indications. It is exciting to explore the potential advantages of this new product compared to current commercial offerings.”
John Greenbaum, senior vice president of clinical and regulatory affairs at Theradaptive, added: “This is Theradaptive’s third breakthrough designation from the FDA and broadens our portfolio of spinal fusion approaches. This significantly increases the number of patients who can potentially benefit from this game-changing technology. Theradaptive has now been granted breakthrough status on three indications for use. No other orthopaedic manufacturer has achieved this.”
Write to us Editor: Anthony Strzalek anthony@bibamedical.com Advertising: Michael Broughton michael@bibamedical.com
United Kingdom: BIBA Medical, Europe 526 Fulham Road, Fulham, London, SW6 5NR TEL: +44 (0)20 7736 8788 Email: info@bibamedical.com United States: BIBA Medical, North America 155 North Wacker Drive, Suite 4250, Chicago, IL 60606 TEL: +1 949 723 9309 Email: info@bibamedical.com Terms and Conditions | Privacy Policy